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onfocal endomicroscopy (CLE) is a new endoscopic tech-
ique that allows to obtain high-resolution layer lining of the
astrointestinal tract imaging. This technique is based on illu-
ination of the mucosa with a laser. In this process, the laser
s absorbed by a ﬂuorescent agent and the reﬂected light is
aptured. The laser is focused at a selected depth in the tis-
ue of interest and the reﬂected light is then redirected to a
etection system for the same lens, excluding the reﬂected
ight from other parts of the mucosa.1–3 This increases signif-
cantly the spatial resolution of the images obtained, and, if
he capturing is very magniﬁed, high-resolution images are
roduced. This technique can be applied during the exami-
ation of endoscopy, and cellular and subcellular structures,
ith extreme detail, as in the conventional microscope.1–3
Currently pCLE systems is a probe-based system (Mauna
ea Technologies, Paris, France Cellvizio); the probe is placed
hrough the biopsy channel of a conventional endoscope. The
epth of view is up to 250 mm with the endoscopic system and
bout 120 mm with the probe-based system. A limited area can
e examined; no more  than 700 mm in the endoscopic-based
ystem and less with the probe-based system. CLE systems
re optimized using a contrast agent. The most widely used
gent is intravenous ﬂuorescein, which is FDA-approved for
phthalmologic imaging of blood vessels when used with a
aser scanning ophthalmoscope.1–4
The use of confocal laser endomicroscopy (CLE), also
nown as confocal ﬂuorescent endomicroscopy and opti-
al endomicroscopy, allows in vivo microscopic imaging of
ells during endoscopy. CLE is proposed for a variety of pur-
oses, especially as a real-time alternative to histology during
olonoscopy and for targeting areas to undergo biopsy in
atients with inﬂammatory bowel disease (IBD), differentia-
ion between neoplastic and benign polyps.2,3
One of the concerns of all the professionals who follow up
he patients with longstanding IBD is the emergence of cancerin this speciﬁc group. It is estimated that the possibility of
onset of colorectal cancer is 2–5 times higher in this group
than in the general population of the same age.4
The CLE technique offers some disadvantages that must be
considered. Among then, we can enumerate:
(1) The learning curve is relatively long and depends on the
training of the specialist to obtain good performance and
interpretation of CLE5–8;
(2) The high cost of probe to be used. The recommendation
is to change the probe after 20 exams. Also the cost of the
equipment to read the images5,6;
(3) The operator dependency with regard the difﬁcult in main-
taining the stability of the probe, for interpretation of
morphologic features, and limited depth of penetration of
the tool.9
(4) The impossibility of examining the entire surface of the
colon using only the endomicroscopic mode. A com-
bination of endomicroscopy with chromoendoscopy in
patients with ulcerative colitis is necessary. Chromoen-
doscopy unmasks circumscript lesions and confocal laser
endomicroscopy can be used to predict intraepithelial neo-
plasias with high accuracy.1–3
We  also enumerate some advantages and indications:
(1) pCLE with ﬂuorescein sodium allowed us to analyze the
cellular structure, connective tissue, and blood cells of the
colonic mucosa in vivo.1–3,5
(2) pCLE could promote in vivo virtual histology and may lead-
ing to an optimized rapid diagnosis of colonic lesions that
has important implications for clinical therapy (e.g., endo-
scopic resection of neoplastic tissue).6–8
(3) pCLE allows in vivo microscopic analysis with impressive
imaging of living cells during colonoscopy and, in some
cases, could establish after identifying the lesion, deﬁning
the security areas after remove the lesion.1,5,6,9
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(4) pCLE promotes the possibility of diagnostic in vivo. This
helps signiﬁcantly on reduction of the number of biopsies
to be performed, restricting to target biopsy and so limiting
the adverse reactions that could occur during multiple ran-
domized biopsies.1,5
(5) pCLE enables to distinguish, with high accuracy, the differ-
entiation between hyperplastic polyps from adenomatous
polyps and gives support for immediate resection of suspi-
cious lesions. The differentiation is usually difﬁcult when
we use only the macroscopic criteria.5,6
Discussion
Currently pCLE has emerged as a new tool of endoscopic imag-
ing modality enabling real-time in vivo histology of the cellular
mucosal layer at a magniﬁcation of 1000-fold. It is neces-
sary application of an exogenous ﬂuorescence agent. These
agents can either be applied systemically (ﬂuorescein) or top-
ically (acriﬂavine hydrochloride, cresyl violet) to the intestinal
mucosa. The use of ﬂuorescence agents enables imaging of
mucosal structures and emphasizes the imaging of features
such as the capillary, architectural, and cellular patterns.
Inﬂammatory bowel disease is an excellent example of the
application of pCLE in clinical practice.
Patients with longstanding UC are at increased risk to
development neoplasia, but it is difﬁcult to detect by white
light endoscopy and random biopsies is necessary to identiﬁed
abnormalities in the mucosa. On the other hand, panendomi-
croscopy of the entire colon is not possible. An option has been
combined pCLE with chromoendoscopy for optimized and
increases the ﬁndings and care of patients under surveillance
for longstanding ulcerative colitis. In this setting, chromoen-
doscopy is used to increase a possibility to discover suspicious
regions and pCLE is used for their immediate characterization.
An important ﬁnding was a possibility to predict of normal
mucosa with an accuracy of over 99% in optical biopsies (with
conventional histopathology as the gold standard).
Although until now there is not a close correspondence
between the conventional endoscopic images and histolog-
ical assessment, this association of tools remains the best
way to diagnose accurately and then treat as early as possi-
ble many  diseases, especially of the colorectal tract, including
chronic inﬂammatory, preneoplastic, and neoplastic diseases.
Based on the ﬁnding that conventional colonoscopy is not
always able to differentiate between neoplastic and non-
neoplastic lesions, in recent years, several studies highlighted
the potential use of CLE, as a new emerging technique, in the
screening of patients for early colorectal cancer detection and
prevention.5,6,9
A prospective study was conducted involved 42 patients
were undergoing a colonoscopy and confocal laser endoscopy.
Acriﬂavine hydrochloride and ﬂuorescein sodium were
used both yielded high-quality images. Whereas acriﬂavine
hydrochloride be strongly labeled to the superﬁcial epithe-
lial cells, ﬂuorescein sodium offers deeper imaging into the
lamina propria. Subsurface analysis during confocal laser
endoscopy allowed detailed analysis of cellular structures.
The presence of neoplastic changes could be predicted with 0 1 6;3  6(1):1–3
high accuracy (sensitivity, 97.4%; speciﬁcity, 99.4%; accuracy,
99.2%).1
Multicenter study was performed for assessing ﬂuorescein
assisted pCLE. No major adverse events occurred in 2272 pro-
cedures, and mild adverse events were recorded in 1.4% of the
procedures, including nausea, vomiting, transient hypoten-
sion, injection site erythema, rash, and epigastric pain.3
There are some alternatives of use which are primarily
intended to improve the sensitivity of colonoscopy, as a chro-
moendoscopy. However, CLE is unique in sense that it is
designed to immediately characterize the cellular structure of
lesions.4 CLE can thus potentially be used to make a diagnostic
of polyp histology, particularly in association with screening or
surveillance colonoscopy, which could allow to leave in place
the small hyperplastic lesions rather than remove them and
send for histologic evaluation. This could reduce risks asso-
ciated with biopsy and reduce the number of biopsies and
histologic evaluations and certainly will improve the detec-
tion of dysplasia. This is an alternative to conducting random
biopsies during surveillance.4,5,9
Recently, the use of CLE was reported in the study of colonic
mucosa in patients with inﬂammatory bowel diseases and in
particular in patients affected by ulcerative colitis. CLE has
an important role in staging the patients with inﬂammatory
bowel diseases. It can be used to assess the grading of coli-
tis and to detect microscopic colitis in endoscopically silent
segments. Moreover, CLE can be used in surveillance pro-
grams especially in high risk patients. Finally, CLE has been
effectively used in diagnosing a biliary dysplasia/neoplasia in
patients with primary sclerosing cholangitis, a pathological
condition frequently associated with IBD, with a coexisting
bile duct stricture.5,6,9
Just like any other advanced and new endoscopy, CLE
technique requires trainings and handling of the endoscopy
and time to learn and interpret with conﬁdence the images
generated.6
The American Society of Gastrointestinal Endoscopy
(ASGE) recommends that the endoscopies exams achieve
≥90% negative predictive value (NPV) and concordance of
≥90% saying that the NPV has to exceed 90% and the predic-
tion of the surveillance interval should be correct in more  than
90% of the cases. These data should always be achieved.5
CLE should be used to enhance the diagnostic arsenal in
the evaluation of these indications, by providing microscopic
information which improves the diagnostic performance of
the physician. In order to actually implement this technology
in the clinical routine, and to ensure good practice, the ini-
tial standardization and the continuing institutional training
programs should be established.5–9
More studies give a very promising glance at possible future
applications, however is need a larger prospective, multicen-
ter trials to prove the advantage of this technique in daily
practice.10,11
ConclusionConfocal laser endomicroscopy (CLE) is a newly  option that
could give us an envision to investigate and to diagnostic the
diseases related to gastrointestinal systems. It allows virtual
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istology of the mucosal layer in real time ongoing endoscopy.
he images obtained through this new technology represent
he beginning of a new era, that will permit detailed visual-
zation of the living cells and the cellular structures that are
elow of the surface of the gut.1,2,5,6,8,11,12
We  will need more  time to implement and make invest-
ents in this ultimate endoscopic imaging tool however, this
s not a dream or future is now a reality.
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